Oranda Therapeutics

Oranda Therapeutics is a rare disease company, focused on acquiring, developing and commercialising innovative medicines to help improve the lives of patients in areas of high unmet need. We have a portfolio of late-stage rare disease assets and are building our organisation to support our first European launch in late 2025. For Investors: We are seeking investment to build a scalable, best in class rare disease commercialisation platform. The Oranda team has extensive BioPharma expertise, specifically in rare disease late-stage development, product licensing, commercialisation (having led over 20 successful European rare disease medicine launches), and lean organisational build out. For Partners: Oranda Therapeutics is seeking to further in-license and acquire rare disease medicines in late-stage clinical development. We are flexible, transparent and committed to forging creative deals and long term collaborations. We have a deep understanding of the critical success factors that drive excellence in late stage development and commercial execution.